Find participating medical centers and current study status in each of them

    Find participating medical centers

    A sponsor-open, randomized, placebo-controlled, phase I study to investigate the pharmacokinetics, safety, and tolerability of RO7223280 in healthy Chinese participants following single IV dose administration

    • Infectious Diseases